The global egg phosphatidylcholine market size was estimated at USD 1,349.0 million in 2025 and is projected to reach USD 2,189.22 million by 2033, growing at a CAGR of 6.4% from 2026 to 2033. Rising adoption of egg phosphatidylcholine in liposomal drug delivery, injectables, and parenteral nutrition is driving market growth, supported by its high biocompatibility, regulatory acceptance, and proven performance in advanced pharmaceutical formulations.